TGM2 and neoplasm: Among IDC patients, increased TG2 expression in tumor stroma correlated significantly with reduced DFS (mean DFS = 110 months) in comparison with patients showing lower stromal TG2 (mean DFS = 130 months, p<0.001, Figure 4b).